# clm_51EBABE50856

subject: Novo Nordisk (/record/novo-nordisk.md)  
predicate: total_equity  
value: 194,047,000,000 DKK  
valid_from: 2025-12-31  
valid_to: null  
published: 2026-02-04  
recorded: 2026-11-08  
confidence: 0.95  
status: valid  
assertable: true  
superseded_by: null  
last_updated: 2026-11-08  
cite: AsOf. "Novo Nordisk total equity: 194,047,000,000 DKK", as of 2025-12-31. Claim clm_51EBABE50856, https://asof.is/claim/clm_51EBABE50856, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/353278/000035327826000012/0000353278-26-000012-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: ifrs-full:Equity in 20-F FY2025, filed 2026-02-04  

## Sources

- https://www.sec.gov/Archives/edgar/data/353278/000035327826000012/0000353278-26-000012-index.htm (primary, SEC EDGAR 20-F FY2025, published 2026-02-04)

## Supersedes

- [Novo Nordisk](/record/novo-nordisk.md) | total_equity | 143,486,000,000 DKK | valid 2024-12-31 to 2025-12-31 | conf 0.95 | superseded | superseded_by [clm_51EBABE50856](/claim/clm_51EBABE50856.md) | [clm_4145313CD790](/claim/clm_4145313CD790.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.